CreativityDMT

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function

This review (2018) presents the historical research into DMT, focussing on its biosynthesis, metabolism, sites of action, methods of detection, and potential physiological and therapeutic roles. The author proposes several areas for further research and highlights the need to resolve the role of endogenous DMT.

Authors

  • Steven Barker

Published

Frontiers in Neuroscience
meta Study

Abstract

This report provides a historical overview of research concerning the endogenous hallucinogen N, N-dimethyltryptamine (DMT), focusing on data regarding its biosynthesis and metabolism in the brain and peripheral tissues, methods and results for DMT detection in body fluids and brain, new sites of action for DMT, and new data regarding its possible physiological and therapeutic roles. Research that further elaborates its consideration as a putative neurotransmitter is also addressed. Taking these studies together, the report proposes several new directions and experiments to ascertain the role of DMT in the brain, including brain mapping of enzymes responsible for the biosynthesis of DMT, further studies to elaborate its presence and role in the pineal gland, a reconsideration of binding site data, and new administration and imaging studies. The need to resolve the “natural” role of an endogenous hallucinogen from the effects observed from peripheral administration are also emphasized.

Available with Blossom Pro

Research Summary of 'N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function'

Introduction

Mori and colleagues frame the review around a long-standing gap in understanding how hallucinogens alter perception and consciousness at a biochemical level. The introduction contrasts the dramatic subjective effects produced by exogenous psychedelics with ordinary regulated phenomena such as dreaming, creativity and near-death experiences, and argues that studying endogenous compounds that resemble administered hallucinogens may reveal mechanisms of normal and extraordinary conscious states. The discovery that N, N-dimethyltryptamine (DMT) occurs naturally prompted renewed interest in whether it functions as an endogenous neuroregulator or neurotransmitter and whether its study could illuminate broader questions about perception and consciousness. The paper aims to synthesise historical and recent data on DMT: its biosynthesis and metabolism in brain and peripheral tissues, methods and results for detecting DMT in body fluids and brain, sites and mechanisms of action (including receptor targets), and possible physiological and therapeutic roles. It also sets out recommended future experiments to clarify DMT's normal role, such as detailed brain mapping of biosynthetic enzymes, evaluation of pineal involvement, improved analytical detection strategies, receptor-binding reassessment and new administration and imaging paradigms. The authors emphasise the importance of distinguishing the effects of peripherally administered, high-dose DMT from the putative physiological role of endogenously produced DMT.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Full Text PDF

Full Paper PDF

Create a free account to open full-text PDFs.

Study Details

  • Study Type
    meta
  • Journal
  • Compound
  • Topic
  • Author
  • APA Citation

    Barker, S. A. (2018). N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function. Frontiers in Neuroscience, 12. https://doi.org/10.3389/fnins.2018.00536

References (42)

Papers cited by this study that are also in Blossom

Serotonergic psychedelics temporarily modify information transfer in humans

Alonso, J. N., Romero, S., Mañanas, M. A. et al. · International Journal of Neuropsychopharmacology (2015)

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F. M., Carvalho, M. et al. · Archives of Toxicology (2015)

A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010

Barker, S., McIlhenny, E. H., Strassman, R. J. · Drug Testing and Analysis (2012)

Antidepressant effects of ketamine in depressed patients

Berman, R. M., Cappiello, A., Anand, A. et al. · Biological Psychiatry (2000)

Interaction of psychoactive tryptamines with biogenic amine transporters and serotonin receptor subtypes

Blough, B. E., Landavazo, A., Decker, A. M. et al. · Psychopharmacology (2014)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

Long-term use of psychedelic drugs is associated with differences in brain structure and personality in humans

Rodríguez-Fornells, A., Ribeiro, S., Sanches, R. F. et al. · European Neuropsychopharmacology (2015)

Dimethyltryptamine (DMT): Subjective effects and patterns of use among Australian recreational users

Cakic, V., Potkonyak, J., Marshall, A. · Drug and Alcohol Dependence (2010)

67 cited
Show all 42 references
Pharmacokinetics of Hoasca alkaloids in healthy humans

Callaway, J. C., Mckenna, D. J., Grob, C. S. et al. · Journal of Ethnopharmacology (1999)

285 cited
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin

Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)

Neural correlates of the LSD experience revealed by multimodal neuroimaging

Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)

Serotonin and brain function: a tale of two receptors

Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)

Classical hallucinogens and neuroimaging: A systematic review of human studies: hallucinogens and neuroimaging

Dos Santos, R. G., Osório, F. L., Crippa, J. A. et al. · Neuroscience and Biobehavioral Reviews (2016)

A possibly sigma-1 receptor mediated role of dimethyltryptamine in tissue protection, regeneration, and immunity

Frecska, E., Szabo, A., Winkelman, M. J. et al. · Translational Neurosciences (2013)

The psychedelic model of schizophrenia: the case of N,N-dimethyltryptamine

Gillin, J. C., Kaplan, J., Stillman, R. et al. · American Journal of Psychiatry (1976)

Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior

Gonza ´lez-Maeso, J., Weisstaub, N. V., Zhou, M. et al. · Neuron (2007)

818 cited
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer

Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)

DPT as an adjunct in psychotherapy of alcoholics

Grof, S., Soskin, R. A., Richards, W. A. et al. · Pharmacopsychiatry (1973)

Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens

Halberstadt, A. L., Geyer, M. A. · Neuropharmacology (2011)

Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision

Hendricks, P. S., Clark, B., Johnson, M. W. et al. · Journal of Psychopharmacology (2014)

89 cited
68 cited
Dreamlike effects of LSD on waking imagery in humans depend on serotonin 2A receptor activation

Kraehenmann, R. ;., Pokorny, D. ;., Vollenweider, L. ;. et al. · Psychopharmacology (2017)

138 cited
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials

Krebs, T. S., Johansen, P. Ø. · Journal of Psychopharmacology (2012)

Hallucinogens

Nichols, D. E. · Pharmacology and Therapeutics (2004)

Psychedelics

Nichols, D. E. · Pharmacological Reviews (2016)

N,N-dimethyltryptamine and the pineal gland: Separating fact from myth

Nichols, D. E. · Journal of Psychopharmacology (2017)

Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Osório, F. L., Sanches, R. F., Macedo, L. et al. · brazilian Journal of Psychiatry (2015)

420 cited
Psychedelics and the human receptorome

Ray, T. S. · PLOS ONE (2010)

265 cited
Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca

Riba, J., Mcilhenny, E. H., Valle, M. et al. · Drug Testing and Analysis (2012)

Human pharmacology of ayahuasca: subjective and cardiovascular effects, monoamine metabolite excretion, and pharmacokinetics

Riba, J., Valle, M., Urbano, G. et al. · Journal of Pharmacology and Experimental Therapeutics (2003)

Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members

Santos, R. G., Landeira-Fernandez, J., Strassman, R. J. et al. · Journal of Ethnopharmacology (2007)

When the endogenous hallucinogenic trace amine N, N-dimethyltryptamine meets the sigma-1 receptor

Hayashi, T., Vaupel, D. B., Su, T. P. · Science Signaling (2009)

Cited By (15)

Papers in Blossom that reference this study

Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial

Falchi, M., Wießner, I., Silva, S. R. B. et al. · European Neuropsychopharmacology (2024)

18 cited
N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q)

Lawrence, D. W., Timmermann, C. · Journal of Psychoactive Drugs (2023)

Preliminary evidence of links between ayahuasca use and the corpus callosum

Bouso, J. C., Simonsson, O., Kurth, F. et al. · Frontiers in Psychiatry (2022)

Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

Jiménez, J. H., Bouso, J. C. · Journal of Psychopharmacology (2022)

Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience

Lawrence, D. W., Carhart-Harris, R. L., Griffiths, R. R. et al. · Research Square (2022)

The clinical pharmacology and potential therapeutic applications of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT)

Reckweg, J., Uthaug, M. V., Szabo, A. et al. · Journal of Neurochemistry (2022)

From Psychiatry to Neurology: Psychedelics as Prospective Therapeutics for Neurodegenerative Disorders

Nichols, C. D., Wiatr, K., Figiel, M. et al. · Journal of Neurochemistry (2021)

63 cited
Sub-acute and long-term effects of ayahuasca on mental health and well-being in healthy ceremony attendants: A replication study

van Oorsouw, K., Uthaug, M. V., Mason, N. L. et al. · Journal of Psychedelic Studies (2021)

17 cited
Show all 15 papers
Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings

Pallavicini, C., Cavanna, F., Zamberlan, F. et al. · Journal of Psychopharmacology (2021)

The ritual use of ayahuasca during treatment of severe physical illnesses: a qualitative study

Maia, L. O., Daldegan-Bueno, D., Tófoli, L.F. · Journal of Psychoactive Drugs (2020)

21 cited
Psychedelics as a Novel Approach to Treating Autoimmune Conditions

Thompson, C., Szabo, A. · Immunology Letters (2020)

Subacute Effects of the Psychedelic Ayahuasca on the Salience and Default Mode Networks

Pasquini, L., Palhano-Fontes, F., Araújo, D. B. · Journal of Psychopharmacology (2020)

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.